Showing 75,701 - 75,720 results of 108,732 for search '(( 5 ((((ng decrease) OR (we decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 1.58s Refine Results
  1. 75701

    Glucose metabolism defects in <i>pex</i> mutant flies. by Michael F. Wangler (544124)

    Published 2017
    “…Glycogen intermediates are also reduced in the <i>pex</i> mutant flies (with the exception of maltohexaose in the <i>pex16</i> mutants). A number of pentose phosphate intermediates such as ribulose 5- phosphate, xylulose 5-phosphate and mannose 6-phosphate are also reduced. …”
  2. 75702

    Cytokines altered by Rolipram administration after spinal cord injury. by Sandra Marie Schaal (306836)

    Published 2013
    “…<p>A cytokine protein array (RayBiotech Inc.) was used to identify changes in the production of 19 cytokines after SCI and/or vehicle or Rolipram administration. …”
  3. 75703

    Table_1_The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis.docx by Ruilin Wang (1452577)

    Published 2023
    “…Outpatient (β<sub>1</sub> = −201.7, 95%CI: −285.4, −117.9) and inpatient (β<sub>1</sub> = −372.1, 95% CI: −643.6, −100.6) drug costs for managing PD significantly decreased when implementing ZMDP. However, for outpatients without health insurance, the trend change in drug costs for managing PD (β<sub>2</sub> = 16.8, 95% CI: 8.0, 25.6) or PD complications (β<sub>2</sub> = 12.6, 95% CI: 5.5, 19.7) significantly increased. …”
  4. 75704

    DataSheet_1_Associations of chest X-ray trajectories, smoking, and the risk of lung cancer in two population-based cohort studies.docx by Ya Liu (205636)

    Published 2023
    “…However, the associations of CXR trajectories, smoking and LC risk remain unknown.</p>Methods<p>A total of 52,486 participants from the PLCO and 22,194 participants from the NLST were included. …”
  5. 75705
  6. 75706
  7. 75707
  8. 75708
  9. 75709
  10. 75710
  11. 75711
  12. 75712
  13. 75713

    The stabilising effect of presynaptic inhibition is robust to details of the transfer function. by Laura Bella Naumann (9221252)

    Published 2020
    “…<p>We qualitatively recover the results obtained for linear transfer functions if the release probability decreases exponentially or as a sigmoid with increasing inhibitory rate. …”
  14. 75714
  15. 75715

    Perturbation of <i>Gata1</i> regulatory dynamics impacts frequency of commitment <i>in silico</i> and <i>in vitro</i>. by Jose Teles (5655964)

    Published 2013
    “…High probability of commitment peaks are more frequent than in wild type simulations (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003197#pcbi-1003197-g005" target="_blank">Figure 5A</a>). …”
  16. 75716

    Network pharmacology-based screening of active constituents of <i>Avicennia marina</i> and their clinical biochemistry related mechanism against breast cancer by Faez Falah Alshehri (15191514)

    Published 2023
    “…Additionally, a molecular docking study demonstrates that active drugs have a higher affinity for the target that may be used to decrease breast cancer. …”
  17. 75717

    p62 levels in Atg mutants, p62 RNAi and p62 overexpression cells. by Karolina Pircs (139061)

    Published 2012
    “…Scalebar in panel B equals 30 µm for panels B–E. <i>Genotypes are: (A) lane 1: w [1118], lane 2: Atg7[d77]/Atg7[d14], lane 3: Atg8a[d4], lane 4: UbiGal4/+; p62[HMS00551]/+, lane 5: UbiGal4/+; p62[HMS00938]/+, lane 6: w [1118], lane 7: Atg8a[d4], lane 8: cgGal4/UAS-p62-GFP; (B) hs-Flp; UAS-LampGFP/p62[KK108193]; Act>CD2>Gal4, UAS-Dcr2/+; (C) hs-Flp; UAS-LampGFP/+; Act>CD2>Gal4, UAS-Dcr2/p62[HMS00551]; (D) hs-Flp; UAS-LampGFP/+; Act>CD2>Gal4, UAS-Dcr2/p62[HMS00938]; (E) hsFlp; UAS-p62-GFP/+; Act>CD2>Gal4,UAS-Dcr2/+.…”
  18. 75718

    Results from test runs in four different conditions. by In Seok Yang (4261207)

    Published 2021
    “…<p>All five barcode factors (A), two factors (GCC and HD; B), one factor (GCC; C) and another single factor (HD; D) were considered in the conditions for selecting an optimal barcode set in each condition. …”
  19. 75719

    Impact of alternative assumptions on life expectancy. by Chara E. Rydzak (242195)

    Published 2010
    “…Depending on the baseline CD4 cell count, life-expectancy was increased by 14.8 to 30.9 months with no late failure (green), and was decreased by 2.8 to 6.6 months with 1.5-fold increase in late failure (orange), and by 5.1 to 11.0 months with a 2-fold increase in late failure (red). …”
  20. 75720